# BioFreedom Pharmacokinetic Study

> **NCT03365492** · NA · COMPLETED · sponsor: **Biosensors Europe SA** · enrollment: 17 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Infarction

## Interventions

- **DEVICE:** BioFreedom™ BA9™ drug-coated stent

## Key facts

- **NCT ID:** NCT03365492
- **Lead sponsor:** Biosensors Europe SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-12
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03365492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03365492, "BioFreedom Pharmacokinetic Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03365492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*